Frequently Asked Questions
Please read HOW IT WORKS >
|Non serious or non life threatening infection not treated by GP or hospital
|Standalone or in addition and simultaneous to antibiotic therapy (ABT)
|ABT failure for any other reason
|ABT allergic or adverse reaction
|ABT side effects not tolerated
|Serious or life threatening bacterial infection
|In addition and simultaneous to ABT. Standalone if ABT not available.
|Viral infection without available drug treatment or after failure of antiviral drug therapy or if antiviral drug adverse reactions or side effects not tolerated
|Vascular insufficiency or neurologically meditated vascular disease or condition affecting drug delivery
|Standalone or in addition and simultaneous to ABT
|First Aid and emergency disaster environment
|Standalone if effect needs to be immediate and sterilizing solution not available or trauma damaged tissues cannot be physically contacted, or in addition and simultaneous to ABT
How long does it take to change an infection with the SIS electromedical technology and equipment?
Each infection and treatment course will be unique.
Yes, it is possible that the Output Current of the direct current (DC) SIS electromedical equipment can be programmed for the treatment of yeast and fungal infections.
No. The SIS electromedical equipment and technology are not appropriate for the treatment of parasite infections.
Does the SIS electromedical technology have the side effects of antibiotics & antiviral drugs in infection treatments?
No. None of the side effects known to be caused by antibiotics and antiviral drugs have ever been reported.
Additionally, none of the side effects of antibiotics were reported by the electromedicine pioneer, American orthopedic surgeon Robert O Becker (1923-2008), nor by his research associates during their many hospital applications of silver-nylon cloth electrode iontophoresis or low intensity direct current (LIDC) treatments of infections and for tissue healing.
Please read HOW IT WORKS >
We do not give medical advice. Here is our general reply to this question for informational purposes only:
A ‘neoplasm’ is the medical term for what is commonly called a ‘malignancy’ or a cancerous growth. Neoplasms are occurrences that form over time as a result of many very complex and simultaneous processes.
The SIS electromedical equipment is not being developed nor claimed to be effective when applied alone in the treatment of neoplasms. We explicitly disclaim that the SIS electromedical equipment can be applied alone to treat neoplasms or cancer disease.
Many neoplasms are known to be caused by infections, in addition to many other simultaneous co-factors; these include but are not limited to the more well known neoplasms that can develop in the liver, stomach and in the cervix of females. There is some research evidence that neoplasms in other organs of the body might also be co-factor caused by infections. In so far as neoplasms have infectious agent co-factor causes, then the SIS electromedical equipment could be applied to treat these infections. However, as explained above, most neoplasms have multiple, simultaneous co-factor causes. The SIS alternating current (AC) electromedical technology can also have cellular normalizing and apoptosis effects.
Is the SIS electromedical device technology for infection treatments like zappers or bioresonance devices?
No. Zappers, Rife machines, and bioresonance devices are all electromagnetic frequency generating devices.
The SIS electromedical device technology for infection treatments utilizes low intensity (amperage) direct current (DC); it does not have an Output Current or Output Voltage frequency, as it is DC device technology.
The SIS electromedical technology for infection treatments has no functional or therapeutic similarity to any frequency generating device.
Please read HOW IT WORKS >
No, they are entirely different. Please continue to the link below to read about the SIS electromedical technology for infection treatments, or first read the information below.
Delivery of ingested silver ions inside the body
‘Colloidal silver’ (ionic silver solution), though certainly of use for surface infections, has limitations for the treatment of internal infections. The human body is often imagined as something like a bathtub of water: if you drop a substance into it, it will homogeneously spread out and automatically go everywhere. The body has ‘compartments’ and ‘barriers’, at every order of anatomical scale, down to the sub-cellular level. Silver ions, as with molecules of any medication, do not automatically reach a target area of infection.
Cellular binding sites and internal anatomical pathways
For ingested colloidal silver solution or spray, there are millions or billions of molecular binding sites available for the (+)positively charged silver (cat)ions, starting high up in the gastrointestinal (GI) tract, before they can reach an infection. Internal pathways are very complex and long. For illustration, the chances of getting a therapeutic dose of silver ions to a kidney infection might be very small. The silver ions must get through the stomach, where they can bind to the stomach’s hydrochloric acid and be used up, then go through at least part of GI tract, and eventually find their way to the renal (kidney supplying) arteries and into the inner compartments of the infected kidney(s). If they are not somehow transported or pass out through the walls of the intestines into the bloodstream, they must further be transported out into the circulatory system via the portal venous system route collecting blood from the intestines back through the liver, then back into the heart, in and out of the lungs, then back into the heart again, and finally into systemic circulation.
Inflammation hinders medication delivery
Localized inflammation of the target tissues can limit the delivery of any medication in general circulation. When inflammatory chemicals are increased in localized areas of infection or injury, they can cause mechanical, obstructing changes inside and around the smallest blood vessels (arterioles). Additionally, these arterioles can also become (chronically) constricted under the control of the smallest motor nerve fibers of the autonomic nervous system, resulting in a reduced amount of any medicine delivered via the bloodstream to those target tissues.
SIS electromedical technology
The operation and effects of the SIS electromedical technology does not depend on blood flow. Operating on the basic physics of electric voltages, electric currents and conductivity, a microorganism-specific low intensity constant direct current (LIDC) is delivered via the shortest possible route, directly to the target infection.
To read about the SIS electromedical technology for infection treatments, please continue to the link below:
Where can I read more about the published medical-scientific supporting articles, data and background to the SIS electromedical technology?
Please see our RESEARCH >